Singapore markets closed

TherapeuticsMD, Inc. (TXMD)

NasdaqGS - NasdaqGS Delayed price. Currency in USD
Add to watchlist
1.9200+0.0300 (+1.59%)
At close: 04:00PM EDT
1.8900 -0.03 (-1.56%)
After hours: 07:23PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close1.8900
Open1.8900
Bid1.5900 x 100
Ask2.1800 x 100
Day's range1.8600 - 1.9300
52-week range1.8600 - 4.7200
Volume14,663
Avg. volume22,437
Market cap22.142M
Beta (5Y monthly)1.04
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Business Wire

    TherapeuticsMD Announces Full Year 2023 Financial Results

    BOCA RATON, Fla., March 29, 2024--TherapeuticsMD, Inc. ("TherapeuticsMD" or the "Company") (NASDAQ: TXMD), a company that owns rights to pharmaceutical royalties, today reported financial results for the full year ended December 31, 2023.

  • Business Wire

    TherapeuticsMD Announces Third Quarter 2023 Financial Results

    BOCA RATON, Fla., November 14, 2023--TherapeuticsMD, Inc. ("TherapeuticsMD" or the "Company") (NASDAQ: TXMD), a company that owns rights to pharmaceutical royalties, today reported financial results for the third quarter ended September 30, 2023.

  • Business Wire

    TherapeuticsMD Announces Second Quarter 2023 Financial Results

    BOCA RATON, Fla., August 14, 2023--TherapeuticsMD, Inc. ("TherapeuticsMD" or the "Company") (NASDAQ: TXMD), a company that owns rights to pharmaceutical royalties, today reported financial results for the second quarter ended June 30, 2023.